# Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013

> **NCT05017688** · NA · UNKNOWN · sponsor: **MaaT Pharma** · enrollment: 40 (estimated)

## Conditions studied

- Intestinal GVHD
- Steroid Refractory GVHD

## Interventions

- **PROCEDURE:** Blood and stool sample collection

## Key facts

- **NCT ID:** NCT05017688
- **Lead sponsor:** MaaT Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-06
- **Primary completion:** 2024-06
- **Final completion:** 2024-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017688, "Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05017688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*